The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Span-America Medical Systems Inc

Nasdaq: SPAN
Last

(U.S.) $18.42

Today's change+0.19 +1.04%
Updated July 6 2:07 PM -4GMT. Delayed by at least 15 minutes.
 

Span-America Medical Systems Inc

Nasdaq: SPAN
Last

(U.S.) $18.42

Today's change+0.19 +1.04%
Updated July 6 2:07 PM -4GMT. Delayed by at least 15 minutes.

Span-America Medical Systems Inc up (U.S.)$0.19

Span-America Medical Systems Inc closed up Monday by (U.S.)$0.19 or 1.04% to (U.S.)$18.42. Over the last five days, shares have gained 0.38% and 8.19% year to date. Shares have underperformed the S&P 500 by 15.17% during the last year.

Key company metrics

  • Open(U.S.) $18.66
  • Previous close(U.S.) $18.23
  • High(U.S.) $18.66
  • Low(U.S.) $18.42
  • Bid / Ask-- / --
  • YTD % change+8.19%
  • Volume498
  • Average volume (10-day)11,835
  • Average volume (1-month)5,941
  • Average volume (3-month)10,451
  • 52-week range(U.S.) $16.57 to (U.S.) $21.62
  • Beta0.42
  • Trailing P/E19.81×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield3.26%
  • Trailing EPS(U.S.) $0.93
Updated July 6 2:07 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 28, 201503/28/2015Jan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue15161313
Total other revenue--------
Total revenue15161313
Gross profit5544
Total cost of revenue101099
Total operating expense14141213
Selling / general / administrative4434
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1111
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1111
Income after tax1110
Income tax, total0000
Net income1110
Total adjustments to net income--------
Net income before extra. items1110
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1110
Inc. avail. to common incl. extra. items1110
Diluted net income1110
Dilution adjustment----0--
Diluted weighted average shares3333
Diluted EPS excluding extraordinary itemsvalue per share0.260.320.220.13
Dividends per sharevalue per share0.151.150.150.14
Diluted normalized EPSvalue per share0.260.320.220.13